← back to search

Raluca Pais

University College London · FR
Area of research
Epidemiology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Diabetes, Cardiovascular Risks, and Lipoproteins, and Diet, Metabolism, and Disease.
h-index
30
citations
4,477
works
114
NIH funding
primary concept
Medicine
email

Recent publications

Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort
Gut 2025cited by 5position: middledoi
Management of patients with type 2 diabetes and MASLD: An overview and joint statement
Diabetes & Metabolism 2025cited by 4position: middledoi
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
Nature Metabolism 2024cited by 215position: middledoi
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study
˜The œLancet. Gastroenterology & hepatology 2023cited by 186position: middledoi
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
˜The œLancet. Gastroenterology & hepatology 2023cited by 181position: middledoi
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study
Hepatology 2023cited by 33position: middledoi
A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials
Journal of Hepatology 2023cited by 14position: firstdoi
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
Journal of Hepatology 2021cited by 345position: middledoi
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
JHEP Reports 2021cited by 45position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bertrand Cariou · University of Cape Town2 papers (2023–2025)Jörn M. Schattenberg · Universitätsklinikum des Saarlandes2 papers (2023–2025) · 1 papers (2025–2025) · 1 papers (2025–2025)Laurent Castéra · Université Paris Cité1 papers (2025–2025)Manal F. Abdelmalek · Mayo Clinic1 papers (2023–2023)Maéva Guillaume · Clinique Pasteur1 papers (2025–2025) · 1 papers (2025–2025)Vlad Ratziu · Inserm1 papers (2023–2023)Julie Dietrich · Amgen (United States)1 papers (2023–2023)Maharajah Ponnaiah · Sorbonne Université1 papers (2025–2025)Rambabu Surabattula · University Medical Center of the Johannes Gutenberg University Mainz1 papers (2025–2025)Yasmina Chouik · Université Claude Bernard Lyon 11 papers (2025–2025)Cyrielle Caussy · Institut National des Sciences Appliquées Rouen Normandie1 papers (2025–2025)Clémence M. Canivet · Wenzhou Medical University1 papers (2025–2025) · 1 papers (2025–2025)Elisabetta Bugianesi · Indiana University – Purdue University Indianapolis1 papers (2025–2025)Jean‐Baptiste Julla · Hôpital Necker-Enfants Malades1 papers (2025–2025)Frédéric Charlotte · Sorbonne Université1 papers (2025–2025)Mazen Noureddin · Chiang Mai University1 papers (2023–2023)